ACTRN12618000557235已完成1 期
A Randomised, Double-Blind, Double-Dummy, Active and Placebo Controlled Phase 1 Study of the Safety, Tolerability and Immunogenicity of the Codavax Influenza Vaccine in healthy volunteers Part 2
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
A study to determine the safety, maximum tolerable dose and ability to provoke an immune response of the Codavax Influenza Vaccine in healthy volunteers.influenzaACTRN12617000254392Clinical Network Services Pty Ltd75
进行中（未招募）
不适用
ot applicableMaintenance/substitution agent for the treatment of opioid dependenceMedDRA version: 14.1Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-003047-22-CZReckitt Benckiser Pharmaceuticals140
进行中（未招募）
不适用
ot applicableMaintenance/substitution agent for the treatment of opioid dependenceMedDRA version: 14.1Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-003047-22-DEReckitt Benckiser Pharmaceuticals140
进行中（未招募）
不适用
ot applicableMaintenance/substitution agent for the treatment of opioid dependenceMedDRA version: 14.1Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-003047-22-ATReckitt Benckiser Pharmaceuticals140
进行中（未招募）
不适用
ot applicableMaintenance/substitution agent for the treatment of opioid dependenceMedDRA version: 14.1Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-003047-22-SEReckitt Benckiser Pharmaceuticals140